Streptococcus Pneumoniae Infection: Clinical Trials

2 trials for Streptococcus Pneumoniae Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Streptococcus Pneumoniae Infection: new trials by email Literature Review of Streptococcus Pneumoniae Infection trials Research Report on Streptococcus Pneumoniae Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial of the 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) (referred to as PCV24) (dose M), PCV24 vaccine (dose H), PCV24 vaccine (dose M) - Streptococcus Pneumoniae Infection
Phase 1 / Phase 2RecruitingCanSino Biologics Inc.8542026-05-242026-08-05
Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Prevnar 13®, V114 1x:1x:1x, V114 2x:2x:2x - Streptococcus Pneumoniae Infection, Pneumococcal Infections
Phase 1 / Phase 2CompletedMerck Sharp & Dohme LLC3412014-01-282019-06-24

Narrower conditions

Pneumococcal Infections (2)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Gram-Positive Bacterial Infections (2)  ·  Infections (2)  ·  Streptococcal Infections (2)

Interventions

13-valent pneumococcal vaccine (2)  ·  CRM197 (non-toxic variant of diphtheria toxin) (1)  ·  Protons (1)  ·  Referral and Consultation (1)  ·  Tetanus Toxoid (1)

Sponsors

CanSino Biologics Inc. (1)  ·  Merck Sharp & Dohme LLC (1)

Countries

China (1)

Top investigators

Zhiqiang Xie, Master (1)

Results publications

PMID 30689507